Loading Events

All Events

RNA: From Therapeutic Modality to Therapeutic Target

October 20 @ 3:00 pm - 4:00 pm

  • This event has passed.

NEVCA’s VC Briefings offer in-depth, interactive discussions between investors, operators, and academics, on the topics at the cutting-edge of the venture landscape. For NEVCA’s upcoming VC Briefing – Co-hosted by Atlas Venture and AbbVie – the discussion will focus on some of the approaches being explored to modulate mRNA processing and translation for therapeutic benefit and explore the promise and challenges of the field.

Details

Date:
October 20
Time:
3:00 pm - 4:00 pm
Event Category:

Venue

VIRTUAL

Organizer

NEVCA
Email:
info@newenglandvc.org
Organizer's Website
Close